nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—CYP3A5—Teniposide—lymphatic system cancer	0.146	0.157	CbGbCtD
Dapsone—CYP2E1—Mitoxantrone—lymphatic system cancer	0.132	0.141	CbGbCtD
Dapsone—CYP2C19—Teniposide—lymphatic system cancer	0.118	0.126	CbGbCtD
Dapsone—CYP2C9—Teniposide—lymphatic system cancer	0.0981	0.105	CbGbCtD
Dapsone—CYP3A7—Vincristine—lymphatic system cancer	0.0938	0.1	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0938	0.1	CbGbCtD
Dapsone—CYP3A5—Vincristine—lymphatic system cancer	0.0704	0.0753	CbGbCtD
Dapsone—CYP3A4—Cytarabine—lymphatic system cancer	0.0579	0.062	CbGbCtD
Dapsone—CYP3A4—Teniposide—lymphatic system cancer	0.057	0.061	CbGbCtD
Dapsone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0399	0.0427	CbGbCtD
Dapsone—CYP3A4—Vincristine—lymphatic system cancer	0.0274	0.0294	CbGbCtD
Dapsone—Localized exfoliation—Bleomycin—lymphatic system cancer	0.00673	0.102	CcSEcCtD
Dapsone—Proteinuria—Fludarabine—lymphatic system cancer	0.00281	0.0427	CcSEcCtD
Dapsone—Protein urine present—Fludarabine—lymphatic system cancer	0.00277	0.0421	CcSEcCtD
Dapsone—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00179	0.0271	CcSEcCtD
Dapsone—Skin exfoliation—Bleomycin—lymphatic system cancer	0.00173	0.0263	CcSEcCtD
Dapsone—Proteinuria—Mitoxantrone—lymphatic system cancer	0.00167	0.0254	CcSEcCtD
Dapsone—Protein urine present—Mitoxantrone—lymphatic system cancer	0.00165	0.0251	CcSEcCtD
Dapsone—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00154	0.0234	CcSEcCtD
Dapsone—Skin exfoliation—Carmustine—lymphatic system cancer	0.00151	0.0229	CcSEcCtD
Dapsone—Vertigo—Mechlorethamine—lymphatic system cancer	0.0015	0.0228	CcSEcCtD
Dapsone—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00135	0.0206	CcSEcCtD
Dapsone—Sinusitis—Fludarabine—lymphatic system cancer	0.0013	0.0197	CcSEcCtD
Dapsone—Pharyngitis—Fludarabine—lymphatic system cancer	0.00123	0.0187	CcSEcCtD
Dapsone—Muscular weakness—Carmustine—lymphatic system cancer	0.00101	0.0154	CcSEcCtD
Dapsone—Tachycardia—Teniposide—lymphatic system cancer	0.000979	0.0149	CcSEcCtD
Dapsone—Muscular weakness—Vincristine—lymphatic system cancer	0.000966	0.0147	CcSEcCtD
Dapsone—Cough—Fludarabine—lymphatic system cancer	0.000943	0.0143	CcSEcCtD
Dapsone—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000867	0.0132	CcSEcCtD
Dapsone—Vomiting—Mechlorethamine—lymphatic system cancer	0.000865	0.0131	CcSEcCtD
Dapsone—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000864	0.0131	CcSEcCtD
Dapsone—Proteinuria—Methotrexate—lymphatic system cancer	0.000834	0.0127	CcSEcCtD
Dapsone—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000828	0.0126	CcSEcCtD
Dapsone—Protein urine present—Methotrexate—lymphatic system cancer	0.000822	0.0125	CcSEcCtD
Dapsone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00082	0.0125	CcSEcCtD
Dapsone—Nausea—Mechlorethamine—lymphatic system cancer	0.000808	0.0123	CcSEcCtD
Dapsone—Abdominal pain—Teniposide—lymphatic system cancer	0.000793	0.012	CcSEcCtD
Dapsone—Body temperature increased—Teniposide—lymphatic system cancer	0.000793	0.012	CcSEcCtD
Dapsone—Erythema—Bleomycin—lymphatic system cancer	0.000792	0.012	CcSEcCtD
Dapsone—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000772	0.0117	CcSEcCtD
Dapsone—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000733	0.0111	CcSEcCtD
Dapsone—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000699	0.0106	CcSEcCtD
Dapsone—Body temperature increased—Fludarabine—lymphatic system cancer	0.000697	0.0106	CcSEcCtD
Dapsone—Erythema—Carmustine—lymphatic system cancer	0.000691	0.0105	CcSEcCtD
Dapsone—Cough—Bleomycin—lymphatic system cancer	0.000691	0.0105	CcSEcCtD
Dapsone—Vision blurred—Carmustine—lymphatic system cancer	0.000651	0.0099	CcSEcCtD
Dapsone—Erythema—Mitoxantrone—lymphatic system cancer	0.000643	0.00977	CcSEcCtD
Dapsone—Vomiting—Teniposide—lymphatic system cancer	0.000638	0.00969	CcSEcCtD
Dapsone—Headache—Teniposide—lymphatic system cancer	0.000628	0.00955	CcSEcCtD
Dapsone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000606	0.0092	CcSEcCtD
Dapsone—Nausea—Teniposide—lymphatic system cancer	0.000596	0.00905	CcSEcCtD
Dapsone—Vertigo—Vincristine—lymphatic system cancer	0.000593	0.00901	CcSEcCtD
Dapsone—Cough—Mitoxantrone—lymphatic system cancer	0.000561	0.00852	CcSEcCtD
Dapsone—Vomiting—Fludarabine—lymphatic system cancer	0.00056	0.00852	CcSEcCtD
Dapsone—Headache—Fludarabine—lymphatic system cancer	0.000552	0.00839	CcSEcCtD
Dapsone—Tachycardia—Carmustine—lymphatic system cancer	0.000551	0.00837	CcSEcCtD
Dapsone—Nausea—Fludarabine—lymphatic system cancer	0.000524	0.00796	CcSEcCtD
Dapsone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000512	0.00778	CcSEcCtD
Dapsone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000511	0.00776	CcSEcCtD
Dapsone—Insomnia—Carmustine—lymphatic system cancer	0.00051	0.00775	CcSEcCtD
Dapsone—Insomnia—Vincristine—lymphatic system cancer	0.000487	0.0074	CcSEcCtD
Dapsone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000461	0.00701	CcSEcCtD
Dapsone—Pancreatitis—Methotrexate—lymphatic system cancer	0.000451	0.00685	CcSEcCtD
Dapsone—Abdominal pain—Carmustine—lymphatic system cancer	0.000446	0.00678	CcSEcCtD
Dapsone—Body temperature increased—Carmustine—lymphatic system cancer	0.000446	0.00678	CcSEcCtD
Dapsone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00044	0.00669	CcSEcCtD
Dapsone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000429	0.00652	CcSEcCtD
Dapsone—Body temperature increased—Vincristine—lymphatic system cancer	0.000426	0.00647	CcSEcCtD
Dapsone—Abdominal pain—Vincristine—lymphatic system cancer	0.000426	0.00647	CcSEcCtD
Dapsone—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000419	0.00637	CcSEcCtD
Dapsone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000415	0.0063	CcSEcCtD
Dapsone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000415	0.0063	CcSEcCtD
Dapsone—Vomiting—Bleomycin—lymphatic system cancer	0.000411	0.00624	CcSEcCtD
Dapsone—Nausea—Bleomycin—lymphatic system cancer	0.000384	0.00583	CcSEcCtD
Dapsone—Pharyngitis—Methotrexate—lymphatic system cancer	0.000365	0.00555	CcSEcCtD
Dapsone—Vomiting—Carmustine—lymphatic system cancer	0.000359	0.00545	CcSEcCtD
Dapsone—Headache—Carmustine—lymphatic system cancer	0.000353	0.00537	CcSEcCtD
Dapsone—Tinnitus—Methotrexate—lymphatic system cancer	0.000343	0.00521	CcSEcCtD
Dapsone—Vomiting—Vincristine—lymphatic system cancer	0.000342	0.0052	CcSEcCtD
Dapsone—Headache—Vincristine—lymphatic system cancer	0.000337	0.00513	CcSEcCtD
Dapsone—Nausea—Carmustine—lymphatic system cancer	0.000335	0.00509	CcSEcCtD
Dapsone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000333	0.00507	CcSEcCtD
Dapsone—Headache—Mitoxantrone—lymphatic system cancer	0.000329	0.00499	CcSEcCtD
Dapsone—Erythema—Methotrexate—lymphatic system cancer	0.00032	0.00487	CcSEcCtD
Dapsone—Nausea—Vincristine—lymphatic system cancer	0.00032	0.00486	CcSEcCtD
Dapsone—Nausea—Mitoxantrone—lymphatic system cancer	0.000312	0.00473	CcSEcCtD
Dapsone—Vision blurred—Methotrexate—lymphatic system cancer	0.000302	0.00459	CcSEcCtD
Dapsone—Vertigo—Methotrexate—lymphatic system cancer	0.000288	0.00437	CcSEcCtD
Dapsone—Cough—Methotrexate—lymphatic system cancer	0.000279	0.00425	CcSEcCtD
Dapsone—Insomnia—Methotrexate—lymphatic system cancer	0.000236	0.00359	CcSEcCtD
Dapsone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000214	0.00325	CcSEcCtD
Dapsone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000207	0.00314	CcSEcCtD
Dapsone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000207	0.00314	CcSEcCtD
Dapsone—Vomiting—Methotrexate—lymphatic system cancer	0.000166	0.00252	CcSEcCtD
Dapsone—Headache—Methotrexate—lymphatic system cancer	0.000164	0.00249	CcSEcCtD
Dapsone—Nausea—Methotrexate—lymphatic system cancer	0.000155	0.00236	CcSEcCtD
